AtaiBeckley (ATAI) Other Non-Current Assets (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Other Non-Current Assets of $1.1 million for Q1 2026, down 1.62% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
AtaiBeckley (ATAI) Other Non-Current Assets (2020 - 2026) Analysis & Trends
AtaiBeckley's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, up 30.59% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.1 million, down from $1.1 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $15.0 million in Q1 2024 and troughed at $382000.0 in Q3 2025.
- A 5-year average of $5.2 million and a median of $3.2 million in 2022 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 30.59% in 2025, while the deepest fall reached 30.59% in 2025.
- AtaiBeckley's Other Non-Current Assets stood at $850000.0 in 2024, then soared by 30.59% to $1.1 million in 2025, then decreased by 1.62% to $1.1 million in 2026.
- Business Quant data shows ATAI's Other Non-Current Assets at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $850000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 382,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.50 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 389,000.00 |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 850,000.00 |
| Dec 31, 2024 | 850,000.00 |
| Sep 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 948,000.00 |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.18 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 8.74 Mn |
| Jun 30, 2022 | 7.59 Mn |
| Mar 31, 2022 | 7.50 Mn |
| Dec 31, 2021 | 7.34 Mn |